Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
28.18
-0.09 (-0.32%)
At close: Mar 4, 2026, 4:00 PM EST
28.05
-0.13 (-0.46%)
After-hours: Mar 4, 2026, 6:50 PM EST

Travere Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,5993,4741,5236781,3521,940
Market Cap Growth
45.37%128.05%124.84%-49.89%-30.30%36.21%
Enterprise Value
2,6053,4801,554515.481,3091,649
Last Close Price
28.1838.2117.428.9921.0331.04
PE Ratio
--131.76-4.27-5.99-4.81-10.31
Forward PE
17.7638.08----
PS Ratio
5.307.086.534.6712.3514.71
PB Ratio
22.3130.2625.793.3731.556.42
P/TBV Ratio
21.8929.6923.263.3331.296.15
P/FCF Ratio
68.8091.95-6.42-2.42-7.26-97.51
P/OCF Ratio
68.8091.95-6.42-2.42-7.26-131.13
EV/Sales Ratio
5.317.096.673.5511.9612.51
EV/EBITDA Ratio
--1672.32-5.55-1.47-4.38-8.83
EV/EBIT Ratio
--55.39-4.80-1.33-4.09-8.27
EV/FCF Ratio
68.9592.11-6.55-1.84-7.03-82.89
Debt / Equity Ratio
2.862.866.802.029.510.87
Debt / EBITDA Ratio
-157.97-157.97-1.43-1.16-1.36-1.40
Debt / FCF Ratio
8.738.70-1.69-1.45-2.19-13.17
Net Debt / Equity Ratio
0.050.050.52-0.81-1.00-0.96
Net Debt / EBITDA Ratio
-2.85-2.85-0.110.460.141.56
Net Debt / FCF Ratio
0.160.16-0.130.580.2314.62
Asset Turnover
0.820.820.340.200.150.19
Inventory Turnover
0.310.310.230.640.750.51
Quick Ratio
2.522.521.983.313.284.58
Current Ratio
2.742.742.083.473.424.70
Return on Equity (ROE)
-57.88%-57.80%-246.75%-308.90%-192.18%-84.66%
Return on Assets (ROA)
-10.70%-10.69%-46.85%-53.15%-44.18%-28.87%
Return on Invested Capital (ROIC)
-52.29%-52.22%-369.68%-455.02%-263.76%-128.76%
Return on Capital Employed (ROCE)
-14.98%-14.98%-64.48%-68.01%-54.07%-34.17%
Earnings Yield
-0.98%-0.76%-23.42%-16.69%-20.78%-9.70%
FCF Yield
1.45%1.09%-15.59%-41.33%-13.78%-1.03%
Buyback Yield / Dilution
-1.08%-1.08%-9.29%-32.80%-2.00%-12.37%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q